China Isotope seeks shareholder approval to renew CNNC transactions

China Isotope & Radiation Corporation announced the proposed renewal of four major, continuing connected transactions with its controlling shareholder, China National Nuclear Corporation (CNNC), and its associates. These framework agreements cover products and services supply, products and services purchase, engineering construction services, and financial services, each for a three-year term ending December 31, 2028. The renewals aim to ensure the continuity of critical operations and financial arrangements for the Group.

The Renewed Products and Services Supply Framework Agreement proposes annual caps of 300m yuan for 2026, 350m yuan for 2027, and 400m yuan for 2028. For the Renewed Products and Services Purchase Framework Agreement, the proposed annual caps are 500m yuan for 2026, 570m yuan for 2027, and 700m yuan for 2028. The Renewed Engineering Construction Services Framework Agreement sets caps at 1.1bn yuan for 2026, 1.4bn yuan for 2027, and 1.3bn yuan for 2028.

The Renewed Financial Services Framework Agreement includes Deposit Services with proposed maximum daily outstanding balance of 5bn yuan and interest income of 100m yuan annually from 2026 to 2028. Other financial services such as Settlement and Entrusted Loans will have a maximum daily outstanding balance of 1bn yuan and service fees of 0.15m yuan annually. Financial Leasing, Factoring, and Asset Securitization Services are each capped at 250m yuan, 1bn yuan, and 1bn yuan respectively per year. These renewals are subject to Independent Shareholders' approval at an upcoming EGM on January 9, 2026.